Pharma Veterans

AI Chatbots and Mental Health – Asrar Qureshi’s Blog Post #1149 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1149 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Ryanneil Masucol Preamble Couple of days ago, I read an article in New York Times Opinion from Laura Reiley titled ‘What My Daughter Told ChatGPT Before She Took Her Life’. The title says what the content is. It is a heartbreaking story but Laura as mother, is still quite unemotional and balanced in her write up. (Link at the bottom) Texas Attorney General Ken Paxton has opened an investigation into artificial intelligence chatbot platforms, including Meta AI Studio and Character.AI, for potentially engaging in deceptive trade practices and misleadingly marketing themselves as mental health tools. These platform may be utilized by vulnerable individ...

Colossal Wrongdoings by Big Pharma – Pfizer and COVID-19 Vaccine – Asrar Qureshi’s Blog Post #1095 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1095 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Charlotte May Credit: Ketut Subiyanto Credit: Shvets Production Preamble This is the last post this series about Big Pharma Wrongdoings. Not that these are the only cases, but these may be considered major in impact. Big Pharma keep doing less than desirable things and mostly get away with it also. Same thing is true in Pakistan where relations are also important along with the size to get away with wrongdoings. As I said in the beginning, the business is business and commercial considerations shall always take precedence over all other things. The Race for a Vaccine: Pfizer’s Global Sprint As the world grappled wi...

Colossal Wrongdoings by Big Pharma – Insulin Price Gouging – Asrar Qureshi’s Blog Post #1092 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1092 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Insulin Vials Insulin Pen Preamble Few drugs in modern medicine are as essential—and as emblematic of life-saving innovation—as insulin. Since its discovery in 1921, insulin has been a lifeline for millions of people living with diabetes. Yet, over the past two decades, a storm of controversy has erupted over the skyrocketing price of insulin in the United States and elsewhere, turning this once-celebrated medical breakthrough into a symbol of pharmaceutical greed and systemic dysfunction. This blog post explores the insulin price gouging crisis from 2000 to the present. We will examine how pharmaceutical companies manipulated p...

Personality Assessment Using AI – Asrar Qureshi’s Blog Post 1046 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1046 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: Andy Barbour Credit: Antoni Shkraba Credit: Eden Kefale This post is inspired on an article written by Eliot Gattegno and Nadav Klein, and published in Knowledge by INSEAD. Link at the end. Preamble This post may be considered as an extension of the previous post with particular focus on AI. One opportunity for deploying technology is to assess personality, an individual’s characteristics that remain consistent across different social situations. People with similar personalities will act similarly in important ways. This means that personality information can be used to predict likely matches and mismatches between colleagues who work together in teams, ...

Ethical Issues in Pharmaceutical Marketing – Asrar Qureshi’s Blog Post #1005 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1005 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Anna Shvets Credit: Eva Bronzini Pharmaceutical Marketing is a different type of marketing because the customer is not consumer. In all other commodities, such as food, appliances, textiles, shoes etc., customer and consumer are the same person, unless someone buys for someone else as a gift which is a fraction of total business. In Pharma marketing, customer is doctor and consumer is patient. Pharma companies are not allowed by law to approach patients directly for selling medicines. Nutritional supplements such as vitamins, health foods, probiotics, energy boosters etc., are not supposed to treat any disease and are therefore allowed to adv...

Longevity – Other Aspects – Asrar Qureshi’s Blog Post #1004 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1004 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Ali Pazani Credit: Boom Credit: Mikhail Nilov Long Life or Longevity is a complicated matter and raises several ethical, social, economic, and global issues. This post highlights some of these aspects. Equity and Access The potential for longevity technologies to be accessible primarily to the wealthy, as is the case at present, raises significant concerns about justice and inequality. If only affluent individuals can afford life-extending treatments, this could exacerbate existing health disparities and create a societal divide where longevity becomes a privilege rather than a universal right. Religious Beliefs Most religions endorse a fixed lifespan allocat...

Artificial Intelligence – Lovers, Haters, and Their Arguments – Part 2 – Asrar Qureshi’s Blog Post #969 Dear Colleagues! This is Asrar Qureshi’s Blog Post 969 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Aathif Aarifeen Credit: Kübra Kuzu Credit: Matheus Bertelli Help for this two-part blogpost has been taken from ChatGPT4o, HubSpot, Mckinsey, and MIT. The Haters of AI – What Concerns Them? Job Displacement and Economic Inequality Critics worry that generative AI will lead to significant job losses, particularly in sectors where routine tasks are prevalent. While new jobs may be created, there is concern that they will not adequately replace the displaced positions, leading to greater economic inequality. In every organization, probably most jobs are repetitive because these tasks must be done every day to keep the or...